Annual Report

Overview

The report describes a transformational 2018 for the company, including the Hong Kong Main Board listing and marketing approval for toripalimab. It reports a group workforce of 600 employees at year-end. Its ESG section covers the listed entities and quantifies Scope 1 and Scope 2 emissions, hazardous and non-hazardous waste, energy consumption and water consumption.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2018
Period: 1 January 2018 – 31 December 2018
Language: English
Pages
File size

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services